Congenital Disorders of Glycosylation
Gene: B3GALNT2
The B3GALNT2 gene encodes an enzyme that transfers N-acetyl galactosamine (GalNAc) in a beta-1,3 linkage to N-acetylglucosamine (GlcNAc).
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A) is an autosomal recessive disorder with congenital muscular dystrophy resulting in muscle weakness early in life and brain and eye anomalies. It is usually associated with delayed psychomotor development and shortened life expectancy. The phenotype includes the alternative clinical designations Walker-Warburg syndrome (WWS) and muscle-eye-brain disease (MEB). The disorder represents the most severe end of a phenotypic spectrum of similar disorders resulting from defective glycosylation of alpha-dystroglycan. Individuals with isolated ID have also been reported, PMID 29273094.
More than 10 unrelated families reported.Created: 19 Dec 2020, 5:48 a.m. | Last Modified: 19 Dec 2020, 5:48 a.m.
Panel Version: 0.264
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, MIM# 615181; MONDO:0014071
Publications
Gene: b3galnt2 has been classified as Green List (High Evidence).
Phenotypes for gene: B3GALNT2 were changed from to Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, MIM# 615181; MONDO:0014071
Publications for gene: B3GALNT2 were set to
Mode of inheritance for gene: B3GALNT2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: B3GALNT2 was added gene: B3GALNT2 was added to Congenital Disorders of Glycosylation_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: B3GALNT2 was set to Unknown